Publikationen, an denen er mitarbeitet Francisco Corzana López (14)

2023

  1. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

  2. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au

2020

  1. A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer

    iScience, Vol. 23, Núm. 6

  2. Structural characterization of an unprecedented lectin-like antitumoral anti-MUC1 antibody

    Chemical Communications, Vol. 56, Núm. 96, pp. 15137-15140

  3. Synthesis, conformational analysis and: In vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment

    Chemical Science, Vol. 11, Núm. 15, pp. 3996-4006

2018

  1. Fluoroproline in MUC1 antigen opens a new via in the development of enhanced cancer diagnostic tools

    International Wageningen Symposium on Organic Chemistry

  2. Oxygen by Carbon Replacement at the Glycosidic Linkage Modulates the Sugar Conformation in Tn Antigen Mimics

    ACS Omega, Vol. 3, Núm. 12, pp. 18142-18152

  3. Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition

    Journal of the American Chemical Society, Vol. 140, Núm. 31, pp. 9952-9960

2017

  1. Design of novel glycopeptide-based cancer vaccines

    16 Congress Spanish Biophysical Society

  2. Effect of glycosylation on mucin-like peptides and implications for molecular recognition by antibodies

    19th European Carbohydrate Symposium EUROCARB

  3. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

  4. Untangling Tn antigen structure and its first hydration shell

    28th Joint Glycobiology Meeting 2017

2016

  1. Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment

    Chemical Science, Vol. 7, Núm. 3, pp. 2294

2014

  1. Designing non-natural cancer vaccines by replacing the methyl group of Thr-10 in MUC1 derivatives

    XI Carbohydrate Symposium